Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Operating Margin (2020 - 2025)

Bioventus (BVS) has disclosed Operating Margin for 6 consecutive years, with 12.34% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 203.0% year-over-year to 12.34%, compared with a TTM value of 9.5% through Dec 2025, up 1073.0%, and an annual FY2025 reading of 9.5%, up 358.0% over the prior year.
  • Operating Margin was 12.34% for Q4 2025 at Bioventus, up from 8.12% in the prior quarter.
  • Across five years, Operating Margin topped out at 46.39% in Q4 2022 and bottomed at 98.58% in Q4 2022.
  • Average Operating Margin over 5 years is 4.28%, with a median of 3.66% recorded in 2024.
  • The sharpest move saw Operating Margin tumbled -9762bps in 2022, then skyrocketed 10358bps in 2023.
  • Year by year, Operating Margin stood at 2.42% in 2021, then skyrocketed by 2021bps to 46.39% in 2022, then crashed by -92bps to 3.51% in 2023, then surged by 194bps to 10.31% in 2024, then grew by 20bps to 12.34% in 2025.
  • Business Quant data shows Operating Margin for BVS at 12.34% in Q4 2025, 8.12% in Q3 2025, and 12.44% in Q2 2025.